Article
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.
Acta neuropathologica communications - 29 Oct 2024
Chang Michael, Sherief Mohamed, Ioannou Maria, Chinnasamy Viveka, Chen Lucy, Frost Michael, Mattson-Hoss Michelle, Sarnoff Herb, Kamson David O, Holdhoff Matthias, Mukherjee Debraj, Bettegowda Chetan, Rincon-Torroella Jordina, Croog Victoria, Huang Peng, Rodriguez Fausto J, Lucas Calixto-Hope G, Schreck Karisa C
Abstract excerpt
BACKGROUND: NF1 inactivation is associated with sensitivity to MEK inhibitor targeted therapy in low-grade and some high-grade gliomas. NF1 loss may also be a harbinger of exploitable vulnerabilities in IDH-wildtype glioblastoma (GBM). Accurate and consistent detection of NF1 loss, however, is fraught given the large gene size, challenges with complete coverage and variant calling upon sequencing, and mechanisms...
Topics
Join the communities discussing this publication.
